Lv1
60 积分 2026-03-29 加入
NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
2天前
已完结
The Autoimmune Diseases
25天前
已完结
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
1个月前
已完结
Advanced progress of the relationship between renin–angiotensin–aldosterone system inhibitors and cancers
2个月前
已完结
Chronic inflammation in the etiology of disease across the life span
2个月前
已完结
Cardiometabolic-kidney indices and machine learning model for predicting all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a longitudinal cohort study
2个月前
已完结
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH
5个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
5个月前
已完结
The Glucagon‐Like Peptide‐1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis
6个月前
已完结
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
6个月前
已完结
皖公网安备34019202002308
